pimagedine has been researched along with Arterial Occlusive Diseases in 4 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "3." | 1.30 | Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase. ( Kis, A; Papp, J; Parratt, J; Végh, A, 1999) |
| "The incidence of ventricular tachycardia was reduced from 75% to 25% (P<0." | 1.30 | Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion. ( György, K; Papp, JG; Parratt, JR; Rastegar, MA; Végh, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, F | 2 |
| Casey, RM | 1 |
| Ross, ME | 1 |
| Iadecola, C | 2 |
| Nagayama, M | 1 |
| Kis, A | 1 |
| Végh, A | 2 |
| Papp, J | 1 |
| Parratt, J | 1 |
| György, K | 1 |
| Rastegar, MA | 1 |
| Papp, JG | 1 |
| Parratt, JR | 1 |
4 other studies available for pimagedine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Base Sequence; Body Water; Brain; Brain Damage, Chro | 1996 |
Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats.
Topics: Animals; Arterial Occlusive Diseases; Brain Ischemia; Cerebral Arteries; Dose-Response Relationship, | 1998 |
Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase.
Topics: Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Cardiac Pacing, Artifici | 1999 |
Delayed protection against ventricular arrhythmias by monophosphoryl lipid-A in a canine model of ischaemia and reperfusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Coronary Vessels | 1999 |